Home Tags U.S. Food and Drug Administration
Tag: U.S. Food and Drug Administration
“Chlorpyrifos is extremely dangerous, especially to the health of our children,” the state attorney general said.
"Companies are creating a myriad of cannabinoid products largely unburdened by any oversight or testing requirements," the attorneys general warned.
However, the FDA did not call for any of the dog food products to be recalled.
The senator warned that the reality television icon was "a powerful influence on young women."
"Blockchain could provide an important new approach to further improving trust in the biopharmaceutical supply chain," IBM's Mark Treshock said.
The attorneys general are part of a seven-state coalition urging the U.S. Food and Drug Administration to expand it scheduled enforcement actions against the sale of e-cigarettes.
Purdue Pharma's Craig Landau said the company wants to make this treatment "available as broadly and quickly as possible."
“Finding improved therapies for this disease is a critical unmet medical need,” said Lewis H. Bender, president and CEO of Intensity Therapeutics.
Roughly 8,000 people in the U.S. are diagnosed with biliary tract cancer each year.
According to the companies, lemborexant is designed to regulate the sleep-wake cycle by dampening wakefulness without impeding the ability to awaken to external stimuli.
"The approval of Vitrakvi is a testament to the relentless prioritization of biology in the drug development process," said Josh Bilenker, CEO of Loxo Oncology.
"The fast track designation recognizes that desmoid tumors have a substantial impact on the lives of patients," said Saqib Islam, CEO of SpringWorks Therapeutics.
The product is a sterile, single-use, disposable, monopolar electrosurgical device for cutting, dissecting, and cauterizing tissue within the digestive tract during endoscopic procedures.
“Accurate, uniform, and comprehensive allergen labeling is essential to enable allergy sufferers to avoid specific ingredients and potentially fatal reactions,” the senators stated.
Stamford-based Loxo Oncology Inc has announced its completion of the rolling submission of a new drug application to the U.S. Food and Drug Administration for the TRK inhibitor treatment larotrectinib.
12Page 1 of 2